When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALBO - Albireo's odevixibat successful in late-stage study; shares up 74%
Albireo Pharma Inc.
Albireo Pharma (NASDAQ:ALBO)announces positive topline results from a Phase 3 clinical trial, PEDFIC 1, evaluating lead drug odevixibat, an ileal bile acid transporter inhibitor, in patients with a rare inherited disorder called progressive familial intrahepatic cholestasis (PFIC).
More news on: Albireo Pharma, Inc., Healthcare stocks news, Stocks on the move,